Respiratory Inhaler Devices Market: Global Industry Analysis and Opportunity Assessment - Key Players are AstraZeneca, GlaxoSmithKline & OMRON - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Respiratory Inhaler Devices Market: Global Industry Analysis and Opportunity Assessment, 2015 - 2025" report to their offering.

This industry offers a 10-year forecast of the global respiratory inhaler devices market between 2015 and 2025. In terms of value, the market is expected to register a CAGR of 4.3% during the projected period. This study demonstrates market dynamics and trends in all seven regions that influence the current environment and future status of the respiratory inhaler devices market over the forecast period.

The increasing prevalence of asthma, COPD and other respiratory diseases coupled with rising awareness is predicted to increase usages of respiratory inhaler devices worldwide. This is expected to bolster growth of the respiratory inhaler devices market over the next five to six years.

Increasing demand for inhalation respiratory inhaler devices for controlling asthma and other respiratory disease, especially among children and elderly population, is expected to drive growth of respiratory inhaler devices market during the forecast period. Companies are focusing on regions and sections where prevalence of asthma, and chronic lung disease are increasing such as Asia Pacific and MEA.

Key Topics Covered:

1. Assumptions and Acronyms Used

2. Research Methodology

3. Executive Summary

4. Respiratory Inhaler Devices Market Overview

5. Global Respiratory Inhaler Devices Market Analysis, By Product

6. Global Market Analysis, By Technology

7. Global Market Analysis, By Disease Indication

8. Global Respiratory Inhaler Devices Market Analysis, By Region

9. North America Respiratory Inhaler Devices Market Analysis

10. Latin America Respiratory Inhaler Devices Market Analysis

11. Western Europe Respiratory Inhaler Devices Market Analysis

12. Eastern Europe Respiratory Inhaler Devices Market Analysis

13. Asia Pacific Excluding Japan Respiratory Inhaler Devices Market Analysis

14. Japan Respiratory Inhaler Devices Market Analysis

15. MEA Respiratory Inhaler Devices Market Analysis

16. Competition Landscape

Companies Mentioned:

  • AstraZeneca
  • Beximco Pharmaceuticals Ltd.
  • Boehringer Ingelheim GmbH
  • Cipla Ltd.
  • GlaxoSmithKline plc
  • Koninklijke Philips N.V.
  • Merck & Co., Inc.
  • OMRON Healthcare Europe B.V.
  • PARI Medical Holding
  • Teva Pharmaceutical Industries Ltd.

For more information visit http://www.researchandmarkets.com/research/xq2j4c/respiratory

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Inhalers and Nebulisers, Respiratory Devices

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Inhalers and Nebulisers, Respiratory Devices